Hypomethylating agents plus venetoclax in younger acute myeloid leukemia
A gentler chemotherapy approach combining two drugs achieves remission and one-year survival rates comparable to or better than intensive treatments in younger leukemia patients.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Circulating Tumor Cells as the Liquid Biopsy Foray into Noninvasive…
Circulating tumor cells detected through blood tests show promise as a noninvasive way to screen for colorectal cancer earlier than current methods allow.
Early cancer detection or preventionUltra-rare functional variants reveal early-onset breast cancer risk…
Researchers identified new genes linked to early-onset breast cancer beyond the well-known BRCA mutations, potentially helping more people understand their inherited risk.
Standard additionGLP-1 Receptor Agonists and Noncardiometabolic Outcomes
GLP-1 drugs used for weight loss appear to offer benefits across multiple organ systems beyond heart and metabolic health, expanding their potential clinical value.
Standard additionEfficacy of tirzepatide, lanifibranor, and resmetirom in metabolic…
Three new medications show varying effectiveness against fatty liver disease, giving doctors better evidence to choose treatments tailored to individual patients.